This week’s Medicare updates include the latest edition of the Medicare Quarterly Provider Compliance Newsletter, two new proposed decision memos on coverage for blood-based biomarker tests and a molecular expression test, updated information in the COVID-19 billing FAQs, and more!
The full U.S Court of Appeals declined to reconsider two recent decisions that upheld CMS’ cuts to reimbursement for certain off-campus provider-based department (PBD) visits and drugs acquired under the 340B program, the American Hospital Association (AHA) announced October 19.
Q: Starting January 1, 2021, CMS will be lowering reimbursement for high throughput novel coronavirus (COVID-19) diagnostic tests from $100 to $75. I understand that if certain requirements are met labs will be eligible to bill for a $25 add on code. How can we meet the requirements for the add on code?
Q: Can an independent radiology facility mail postcards with a reminder that it's time for patients to schedule? The postcard would include the patient's name and address, obviously, but then either a check mark by screening mammogram or the words “follow-up exam.”
Case management lost a significant figure on August 30 when Karen Zander passed away at the age of 72. Considered a pioneer in the field, Karen devoted herself to advancing case management and making contributions and role modifications to match the rapid, changing needs of modern healthcare.
